Clinicopathological Spectrum of Gastrointestinal Stromal Tumours: A Case Series
DOI:
https://doi.org/10.21276/apalm.3810Keywords:
gastrointestinal stromal tumor, GIST, tyrosine kinase inhibitor, KIT mutation, PDGFRA mutationAbstract
Gastrointestinal stromal tumors (GISTs) are rare neoplasms of the gastrointestinal tract, accounting for less than 1% of all primary GIT tumors. In this small sized series, GISTs were identified in both the stomach and small intestine, highlighting the anatomical variability of these tumors. The primary objective of this case series was to characterize the clinicopathological features, histomorphology, immunohistochemical profile, and risk stratification of GISTs. Four patients diagnosed with GIST between January 2024 and December 2024 at a tertiary care hospital in Gujarat, India, were included in the study. The patients were adults aged 37–58 years. Spindle cell morphology was the predominant histological pattern observed, consistent with the typical morphology of GISTs. The novelty in this case series highlights the diagnostic utility of histomorphology and immunohistochemistry in resource-limited settings and underscores the importance of risk stratification in guiding management.References
1. Helbing A, Menon G. Gastrointestinal Stromal Tumors. [Updated 2025 Sep 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554541/
2. Mohamed A, Al Qureshi T, Rakha SM. Giant Gastrointestinal Stromal Tumors of the Stomach Successfully Treated With Laparoscopic Resection: Case Report and Literature Review. Cureus. 2021 Feb 27;13(2):e13584. doi: 10.7759/cureus.13584. PMID: 33815988; PMCID: PMC8009453.
3. Kanthan R, Senger J, Ahmed S, Kanthan S. Gastrointestinal Stromal Tumors in the 21st Century. Journal of Cancer Therapy. 2014;5:769-796. doi: 10.4236/jct.2014.58086.
4. Jumniensuk C, Charoenpitakchai M. Gastrointestinal stromal tumor: clinicopathological characteristics and pathologic prognostic analysis. World J Surg Oncol. 2018 Dec 3;16(1):231. doi: 10.1186/s12957-018-1532-1. PMID: 30509310; PMCID: PMC6277996.
5. Sawaki A. Rare gastrointestinal stromal tumors (GIST): omentum and retroperitoneum. Transl Gastroenterol Hepatol. 2017 Dec 19;2:116. doi: 10.21037/tgh.2017.12.07. PMID: 29354773; PMCID: PMC5762994.
6. Zheng S, Chen LR, Wang HJ, Chen SZ. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor. Hepatogastroenterology. 2007 Dec;54(80):2285-90. PMID: 18265649.
7. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 2001;438(1):1–12.
8. Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin. 2017 Mar;67(2):93-99. doi: 10.3322/caac.21388. Epub 2017 Jan 17. PMID: 28094848.
9. Fletcher CDM, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33(5):459–465.
10. Nilsson B, Bümming P, Meis-Kindblom JM, et al. Gastrointestinal stromal tumors: incidence, prevalence, clinical course, and prognostication in the preimatinib era—A population-based study in western Sweden. Cancer. 2005;103(4):821–829.
11. Rosai J. Rosai and Ackerman's Surgical Pathology. 10th ed. Philadelphia: Elsevier; 2011. p. 669–686.
12. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, editors. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. Lyon: IARC; 2013. p. 164–167.
13. West RB, Corless CL, Chen X, et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol. 2004;165(1):107–113.
14. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231(1):51–58.
15. Casali PG, Abecassis N, Aro HT, et al. Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv68–iv78.
16. Agarwal R, Gupta A, Kakkar N, et al. Gastrointestinal stromal tumors: a clinicopathologic study from a tertiary care center in North India. Indian J Pathol Microbiol. 2012;55(4):469–473.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Saloni Rajeshbhai Kansagra, Rupal Jaymin Shah, Bhumi Nareshbhai Patel
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
How to Cite
